ovarian hyper stimulation syndrome in two spontaneous pregnancies
نویسندگان
چکیده
discussion the presence of ohss in spontaneous pregnancy especially in familial pattern may lead us to evaluate some endogenous pathogenic factors. case presentation in this case report, we are going to present two cases of ohss occurring in spontaneously conceived pregnancies. one of the patients mentioned the history of this syndrome in her sister, and the other one confronted with this syndrome in her second pregnancy. both of them referred to the hospital with typical symptoms and signs of ohss. they did not have polycystic ovary syndrome (pcos) and any other problem in pregnancy. thrombophilia workup, tumor markers, renin-aldosterone and thyroid function tests were normal. introduction ovarian hyper stimulation syndrome (ohss) occurs mainly after excessive stimulation of the ovaries by exogenous gonadotropin administered in the context of ovulation induction and in vitro fertilization procedures (iatrogenic ohss). spontaneous ohss is a rare event. such cases would explain other etiologies except ovulation induction. in this case report, we have presented two cases of ohss in spontaneously conceived pregnancies.
منابع مشابه
Outcomes of assisted reproduction treatment after dopamine agonist -cabergoline- for prevention of ovarian hyper stimulation syndrome
Background: Release of vascular endothelial growth factor (VEGF) by ovaries in response to HCG administration is one of the main mechanisms of ovarian hyper stimulation syndrome. Since Dopamine/dopamine receptor2 (Dp-r2) pathway activity -mediated by VEGF/ Vascular endothelial growth factor receptor 2 (VEGFR-2) signaling-, is associated with angiogenic events, dopamine agonists were used for th...
متن کاملoutcomes of assisted reproduction treatment after dopamine agonist -cabergoline- for prevention of ovarian hyper stimulation syndrome
background: release of vascular endothelial growth factor (vegf) by ovaries in response to hcg administration is one of the main mechanisms of ovarian hyper stimulation syndrome. since dopamine/dopamine receptor2 (dp-r2) pathway activity -mediated by vegf/ vascular endothelial growth factor receptor 2 (vegfr-2) signaling-, is associated with angiogenic events, dopamine agonists were used for th...
متن کاملSpontaneous ovarian hyperstimulation syndrome.
Spontaneous forms of the ovarian hyperstimulation syndrome (sOHSS) are nearly always reported between 8 and 14 weeks of pregnancy and also with follicle-stimulating hormone (FSH) producing pituitary adenoma. The syndrome has been previously reported in rare instances of increased production of human chorionic gonadotrophin (hCG) such as multiple pregnancies, hydatiforme mole, polycystic ovary d...
متن کاملoutcomes of assisted reproduction treatment after dopamine agonist -cabergoline- for prevention of ovarian hyper stimulation syndrome
background: release of vascular endothelial growth factor (vegf) by ovaries in response to hcg administration is one of the main mechanisms of ovarian hyper stimulation syndrome. since dopamine/dopamine receptor2 (dp-r2) pathway activity -mediated by vegf/ vascular endothelial growth factor receptor 2 (vegfr-2) signaling-, is associated with angiogenic events, dopamine agonists were used for th...
متن کاملOnm-5: Evaluation of Patients with Ovarian Hyper Stimulation Syndrome and Medical Care in Infertility Treatment Course in Royan Research Center from 2010 to 2012
Background: Ovarian Hyper stimulation syndrome (OHSS) is infrequent and iatrogenic complication of ovary stimulation by Follicular stimulating hormone (FSH). OHSS is a probable complication of ovulation stimulating drugs, including clomiphene citrate and gonadotropins. Development of infertility treatment with the aim of reaching the desirable number of oocyte and embryo has led to ovary stimul...
متن کاملtreatment results of high dose cabergoline as an adjuvant therapy in six patients with established severe ovarian hyper stimulation syndrome
background: the beneficial role of cabergoline as a prophylactic agent to prevent ovarian hyper stimulation syndrome (ohss) among high-risk patients has been demonstrated in previous studies. but data for its role as a treatment for established severe ohss is still limited. we represent the treatment results of high dose oral cabergoline in management of six patients after the syndrome is estab...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
razavi international journal of medicineجلد ۲، شماره ۱، صفحات ۰-۰
کلمات کلیدی
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023